These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38097819)

  • 1. Microbiome subsets determine tumor prognosis and molecular characteristics of clear-cell renal cell carcinoma: a multi-center integrated analysis of microbiome, metabolome, and transcriptome data.
    Chen W; Pan X; Zhou W; Xu D; Chen J; Dong K; Chen W; Rini B; Cui X
    Front Med; 2024 Apr; 18(2):399-402. PubMed ID: 38097819
    [No Abstract]   [Full Text] [Related]  

  • 2. An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma.
    Hakimi AA; Reznik E; Lee CH; Creighton CJ; Brannon AR; Luna A; Aksoy BA; Liu EM; Shen R; Lee W; Chen Y; Stirdivant SM; Russo P; Chen YB; Tickoo SK; Reuter VE; Cheng EH; Sander C; Hsieh JJ
    Cancer Cell; 2016 Jan; 29(1):104-116. PubMed ID: 26766592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma.
    Wu P; Liu JL; Pei SM; Wu CP; Yang K; Wang SP; Wu S
    BMC Cancer; 2018 Mar; 18(1):287. PubMed ID: 29534679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Gene Signature of Survival Prediction for Kidney Renal Cell Carcinoma by Multi-Omic Data Analysis.
    Hu F; Zeng W; Liu X
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale transcriptome profiles reveal robust 20-signatures metabolic prediction models and novel role of G6PC in clear cell renal cell carcinoma.
    Xu WH; Xu Y; Tian X; Anwaier A; Liu WR; Wang J; Zhu WK; Cao DL; Wang HK; Shi GH; Qu YY; Zhang HL; Ye DW
    J Cell Mol Med; 2020 Aug; 24(16):9012-9027. PubMed ID: 32567187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiogenomics in Clear Cell Renal Cell Carcinoma: Correlations Between Advanced CT Imaging (Texture Analysis) and MicroRNAs Expression.
    Marigliano C; Badia S; Bellini D; Rengo M; Caruso D; Tito C; Miglietta S; Palleschi G; Pastore AL; Carbone A; Fazi F; Petrozza V; Laghi A
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819878458. PubMed ID: 31564221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumoral morphologic and molecular heterogeneity of rhabdoid renal cell carcinoma: challenges for personalized therapy.
    Singh RR; Murugan P; Patel LR; Voicu H; Yoo SY; Majewski T; Mehrotra M; Wani K; Tannir N; Karam JA; Jonasch E; Wood CG; Creighton CJ; Medeiros LJ; Broaddus RR; Tamboli P; Baggerly KA; Aldape KD; Czerniak B; Luthra R; Sircar K
    Mod Pathol; 2015 Sep; 28(9):1225-35. PubMed ID: 26111976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the mechanism of clear cell renal cell carcinoma metastasis and key genes based on multi-tool joint analysis.
    Yang H; Li W; Lv Y; Fan Q; Mao X; Long T; Xie L; Dong C; Yang R; Zhang H
    Gene; 2019 Dec; 720():144103. PubMed ID: 31491435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated transcriptomic and metabolomic analysis shows that disturbances in metabolism of tumor cells contribute to poor survival of RCC patients.
    Popławski P; Tohge T; Bogusławska J; Rybicka B; Tański Z; Treviño V; Fernie AR; Piekiełko-Witkowska A
    Biochim Biophys Acta Mol Basis Dis; 2017 Mar; 1863(3):744-752. PubMed ID: 28012969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with ClearCode34-identified molecular subtypes of clear cell renal cell carcinoma represent unique populations with distinct comorbidities.
    Haake SM; Brooks SA; Welsh E; Fulp WJ; Chen DT; Dhillon J; Haura E; Sexton W; Spiess PE; Pow-Sang J; Rathmell WK; Fishman M
    Urol Oncol; 2016 Mar; 34(3):122.e1-7. PubMed ID: 26546482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic profile and immunohistochemical study of clear cell renal carcinoma: Pathological-anatomical correlation and prognosis.
    Diez-Calzadilla NA; Noguera Salvá R; Soriano Sarrió P; Martínez-Jabaloyas JM
    Cancer Treat Res Commun; 2021; 27():100374. PubMed ID: 33932757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of prognostic signature based on RNA binding proteins related genes analysis in clear cell renal cell carcinoma.
    Chen Q; Li ZL; Fu SQ; Wang SY; Liu YT; Ma M; Yang XR; Xie WJ; Gong BB; Sun T
    Aging (Albany NY); 2021 Jan; 13(3):3926-3944. PubMed ID: 33461173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DAB2IP Plays Important Clinical Significance and Correlates With Immune Infiltration in Renal Cell Carcinoma.
    Cao H; Zhang J; Wang W
    Technol Cancer Res Treat; 2020; 19():1533033820936682. PubMed ID: 32583730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma.
    Sun JX; Xia QD; Liu CQ; Xu JZ; Xun Y; Lu JL; Hu J; Wang SG
    Dis Markers; 2021; 2021():8800358. PubMed ID: 34512816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening, identification and validation of CCND1 and PECAM1/CD31 for predicting prognosis in renal cell carcinoma patients.
    Yang JF; Shi SN; Xu WH; Qiu YH; Zheng JZ; Yu K; Song XY; Li F; Wang Y; Wang R; Qu YY; Zhang HL; Zhou XQ
    Aging (Albany NY); 2019 Dec; 11(24):12057-12079. PubMed ID: 31850854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma.
    Munari E; Marchionni L; Chitre A; Hayashi M; Martignoni G; Brunelli M; Gobbo S; Argani P; Allaf M; Hoque MO; Netto GJ
    Hum Pathol; 2014 Jun; 45(6):1130-8. PubMed ID: 24703100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis.
    Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X
    J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of circRNA-based ceRNA network to reveal the role of circRNAs in the progression and prognosis of metastatic clear cell renal cell carcinoma.
    Wei X; Dong Y; Chen X; Ren X; Li G; Wang Y; Wang Y; Zhang T; Wang S; Qin C; Song N
    Aging (Albany NY); 2020 Nov; 12(23):24184-24207. PubMed ID: 33223511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma.
    Xu W; Tao J; Zhu W; Liu W; Anwaier A; Tian X; Su J; Shi G; Huang H; Wei G; Li C; Qu Y; Zhang H; Ye D
    Front Immunol; 2021; 12():734646. PubMed ID: 34795663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
    Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
    Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.